- Market Realist•2 hours ago
Pfizer is set to release its 3Q16 earnings on November 1. Analysts estimate EPS of $0.62 for 3Q16. PFE’s stock has fallen ~4% in the past 12 months.
- TheStreet.com•8 hours ago
Pfizer will showcase third-quarter results, but investors will be more focused on the potential for its Inflectra drug, as well as its outlook on M&A.
- Market Realist•9 hours ago
On September 28, 2016, Pfizer (PFE) announced the completion of its acquisition of Medivation for around $14 billion.
Pfizer Inc. (PFE)
NYSE - NYSE Delayed Price. Currency in USD
|Bid||31.95 x 100|
|Ask||32.00 x 2400|
|Day's Range||31.88 - 32.56|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.31|
|Avg Vol (3m)||19,193,012|
|Dividend & Yield||1.20 (3.70%)|